Vicarious Surgical (RBOT) Competitors $5.34 -0.07 (-1.29%) Closing price 04/17/2025 03:57 PM EasternExtended Trading$5.35 +0.01 (+0.19%) As of 04/17/2025 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RBOT vs. AVR, MLSS, NTRB, APT, SPAI, COCH, CLGN, LFWD, POAI, and NAOVShould you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Anteris Technologies Global (AVR), Milestone Scientific (MLSS), Nutriband (NTRB), Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), ReWalk Robotics (LFWD), Predictive Oncology (POAI), and NanoVibronix (NAOV). These companies are all part of the "surgical appliances & supplies" industry. Vicarious Surgical vs. Anteris Technologies Global Milestone Scientific Nutriband Alpha Pro Tech Safe Pro Group Inc. Common Stock Envoy Medical CollPlant Biotechnologies ReWalk Robotics Predictive Oncology NanoVibronix Anteris Technologies Global (NASDAQ:AVR) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, community ranking, dividends and earnings. Is AVR or RBOT more profitable? Anteris Technologies Global's return on equity of 0.00% beat Vicarious Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Anteris Technologies GlobalN/A N/A N/A Vicarious Surgical N/A -81.46%-63.62% Do insiders and institutionals believe in AVR or RBOT? 47.3% of Vicarious Surgical shares are held by institutional investors. 11.7% of Vicarious Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts recommend AVR or RBOT? Anteris Technologies Global presently has a consensus price target of $16.50, suggesting a potential upside of 472.92%. Vicarious Surgical has a consensus price target of $9.25, suggesting a potential upside of 73.22%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than Vicarious Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anteris Technologies Global 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Vicarious Surgical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community favor AVR or RBOT? Vicarious Surgical received 4 more outperform votes than Anteris Technologies Global when rated by MarketBeat users. However, 100.00% of users gave Anteris Technologies Global an outperform vote while only 32.00% of users gave Vicarious Surgical an outperform vote. CompanyUnderperformOutperformAnteris Technologies GlobalOutperform Votes4100.00% Underperform VotesNo VotesVicarious SurgicalOutperform Votes832.00% Underperform Votes1768.00% Which has preferable valuation and earnings, AVR or RBOT? Anteris Technologies Global has higher revenue and earnings than Vicarious Surgical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnteris Technologies Global$2.71M38.27N/AN/AN/AVicarious SurgicalN/AN/A-$71.07M-$10.85-0.49 Does the media refer more to AVR or RBOT? In the previous week, Anteris Technologies Global had 1 more articles in the media than Vicarious Surgical. MarketBeat recorded 1 mentions for Anteris Technologies Global and 0 mentions for Vicarious Surgical. Anteris Technologies Global's average media sentiment score of 1.82 beat Vicarious Surgical's score of 0.00 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Overall Sentiment Anteris Technologies Global Very Positive Vicarious Surgical Neutral SummaryAnteris Technologies Global beats Vicarious Surgical on 9 of the 12 factors compared between the two stocks. Get Vicarious Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RBOT vs. The Competition Export to ExcelMetricVicarious SurgicalSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$31.67M$8.59B$5.31B$18.41BDividend YieldN/A1.70%5.45%4.18%P/E Ratio-0.5218.6621.9431.09Price / SalesN/A70.67380.9426.54Price / CashN/A19.6738.2617.53Price / Book0.324.846.454.30Net Income-$71.07M$284.66M$3.22B$1.02B7 Day Performance-0.02%1.68%5.85%1.42%1 Month Performance-33.08%-8.58%-9.55%-7.92%1 Year Performance-38.19%-20.52%11.83%1.69% Vicarious Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RBOTVicarious Surgical2.3579 of 5 stars$5.34-1.3%$9.25+73.2%-36.7%$31.67MN/A-0.523AVRAnteris Technologies GlobalN/A$2.58+4.5%$16.50+539.5%N/A$92.94M$2.71M0.00138News CoveragePositive NewsGap UpHigh Trading VolumeMLSSMilestone Scientific2.0195 of 5 stars$0.91+1.6%$1.25+36.8%+63.5%$71.19M$8.88M-13.0630Analyst ForecastNews CoverageGap UpNTRBNutriband2.9403 of 5 stars$4.96+5.1%$13.00+162.1%+28.5%$55.09M$2.02M-6.9910Gap DownAPTAlpha Pro TechN/A$4.25+2.2%N/A-30.0%$46.21M$57.84M11.49120SPAISafe Pro Group Inc. Common StockN/A$2.22-1.3%N/AN/A$33.68M$2.17M0.0011COCHEnvoy Medical1.308 of 5 stars$1.36+6.7%$9.00+561.8%-73.5%$29.01M$225,000.00-0.9634News CoverageGap UpCLGNCollPlant Biotechnologies1.8551 of 5 stars$2.45+0.4%$12.50+410.2%-53.6%$28.07M$515,000.00-1.5970Positive NewsLFWDReWalk Robotics2.6453 of 5 stars$1.44+0.7%$9.00+525.0%-70.3%$15.31M$25.66M-0.5860Short Interest ↓POAIPredictive Oncology1.4128 of 5 stars$0.96-4.0%$3.00+212.5%-19.4%$8.58M$1.62M-0.3130Short Interest ↑NAOVNanoVibronix0.1323 of 5 stars$7.75+14.5%N/A-18.6%$5.88M$2.56M-6.3020Short Interest ↑Gap Up Related Companies and Tools Related Companies AVR Alternatives MLSS Alternatives NTRB Alternatives APT Alternatives SPAI Alternatives COCH Alternatives CLGN Alternatives LFWD Alternatives POAI Alternatives NAOV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RBOT) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
